Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)

Federal funding opportunity RFA-HL-26-017 from National Institutes of Health (Department of Health and Human Services).

Apply on Grants.gov →Application closes December 23, 2027

Program funding history

Synopsis

Who can apply

• Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
• Independent school districts
• State governments
• Public and State controlled institutions of higher education
• Public housing authorities/Indian housing authorities
• For profit organizations other than small businesses
• County governments
• Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
• Others (see text field entitled "Additional Information on Eligibility" for clarification)
• Native American tribal governments (Federally recognized)
• City or township governments
• Small businesses
• Native American tribal organizations (other than Federally recognized tribal governments)
• Private institutions of higher education
• Special district governments

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

How to apply

Similar grants

• Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)
  RFA-HL-26-018 · National Institutes of Health · closes December 23, 2027
• Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)
  RFA-HL-26-019 · National Institutes of Health · closes December 23, 2027
• Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)
  RFA-HL-26-020 · National Institutes of Health · closes December 23, 2027
• HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
  RFA-NS-27-007 · National Institutes of Health · closes February 20, 2029
• Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)
  RFA-HL-26-016 · National Institutes of Health · closes December 23, 2027
• NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
  PA-25-302 · National Institutes of Health · closes January 7, 2028